Authors:
Peiffert, D
Giovannini, M
Ducreux, M
Michel, P
Francois, E
Lemanski, C
Mirabel, X
Cvitkovic, F
Luporsi, E
Conroy, T
Gerard, JP
Citation: D. Peiffert et al., High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study, ANN ONCOL, 12(3), 2001, pp. 397-404
Authors:
Bensmaine, MA
Marty, M
de Gramont, A
Brienza, S
Levi, F
Ducreux, M
Francois, E
Gamelin, E
Bleiberg, H
Cvitkovic, E
Citation: Ma. Bensmaine et al., Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) +/- folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients, BR J CANC, 85(4), 2001, pp. 509-517
Authors:
Bensmaine, MA
de Gramont, A
Brienza, S
Marty, M
Levi, F
Ducreux, M
Francois, E
Gamelin, E
Bleiberg, H
Bleuzen, P
Simon, J
Cvitkovic, E
Citation: Ma. Bensmaine et al., Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/- folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients, EUR J CANC, 36(18), 2000, pp. 2335-2343
Authors:
Seitz, JF
Milan, C
Giovannini, M
Dumas, F
Cauvin, JM
Conroy, T
Francois, E
Renard, P
Votte-Lambert, A
Paillot, B
Bedenne, L
Citation: Jf. Seitz et al., Concurrent concentrated chemoradiation therapy in squamous cell carcinoma of the esophagus: long term results of a national multicenter phase II study in 122 inoperable patients (FFCD 8803), GASTRO CL B, 24(2), 2000, pp. 201-210
Authors:
Brienza, S
Bensmaine, MA
Soulie, P
Louvet, C
Gamelin, E
Francois, E
Ducreux, M
Marty, M
Andre, T
de Braud, F
Bleiberg, H
Segal, V
Itzhaki, M
Cvitkovic, E
Citation: S. Brienza et al., Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): Results from the European compassionate-use program, ANN ONCOL, 10(11), 1999, pp. 1311-1316
Authors:
Andre, T
Bensmaine, MA
Louvet, C
Francois, E
Lucas, V
Desseigne, F
Beerblock, K
Bouche, O
Carola, E
Merrouche, Y
Morvan, F
Dupon-Andre, G
de Gramont, A
Citation: T. Andre et al., Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracilinfusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen, J CL ONCOL, 17(11), 1999, pp. 3560-3568
Authors:
Hastier, P
Buckley, MJM
Francois, E
Peten, EP
Dumas, R
Caroli-Bosc, FX
Delmont, JP
Citation: P. Hastier et al., A prospective study of pancreatic disease in patients with alcoholic cirrhosis: comparative diagnostic value of ERCP and EUS and long-term significance of isolated parenchymal abnormalities, GASTROIN EN, 49(6), 1999, pp. 705-709